Trial Profile
Vancomycin Versus Daptomycin for the Treatment of Methicillin-resistant Staphylococcus Aureus Bacteremia Due to Isolates With High Vancomycin Minimum Inhibitory Concentrations (MICs).
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 13 Dec 2023
Price :
$35
*
At a glance
- Drugs Daptomycin (Primary) ; Vancomycin
- Indications Methicillin-resistant Staphylococcus aureus infections
- Focus Therapeutic Use
- 03 Aug 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 03 Aug 2011 Actual initiation date (Jun 2011) added as reported by ClinicalTrials.gov.
- 09 Feb 2011 New trial record